Selected research
Market Outlook & Growth Opportunities
Global Plant-based Immune Health Supplement Market Outlook and Growth Opportunities 2026
Market perspective
The global Plant-based Immune Health Supplement market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Plant-based Immune Health Supplement is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Plant-based Immune Health Supplement is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Plant-based Immune Health Supplement is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Plant-based Immune Health Supplement market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Plant-based Immune Health Supplement market include China New Era Group, INFINITUS, PERFECT, By-health, Suntory, Bayer AG, Amway, USANA Health Sciences and Swisse, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Plant-based Immune Health Supplement market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Plant-based Immune Health Supplement and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Plant-based Immune Health Supplement revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Plant-based Immune Health Supplement market.
Plant-based Immune Health Supplement Segment by Company
China New Era Group
INFINITUS
PERFECT
By-health
Suntory
Bayer AG
Amway
USANA Health Sciences
Swisse
GNC
Glanbia
Blackmores
Plant-based Immune Health Supplement Segment by Type
Powder
Tablets
Soft Gels
Liquid
Plant-based Immune Health Supplement Segment by Application
Pharmacies and Drug Stores
Online Retail
Supermarkets
Convenience Stores
Others
Plant-based Immune Health Supplement Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global Plant-based Immune Health Supplement status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Plant-based Immune Health Supplement key companies, revenue, market share, and recent developments.
3. To split the Plant-based Immune Health Supplement breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Plant-based Immune Health Supplement market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Plant-based Immune Health Supplement significant trends, drivers, influence factors in global and regions.
6. To analyze Plant-based Immune Health Supplement competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Plant-based Immune Health Supplement market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Plant-based Immune Health Supplement and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Plant-based Immune Health Supplement.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Plant-based Immune Health Supplement industry.
Chapter 3: Detailed analysis of Plant-based Immune Health Supplement company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Plant-based Immune Health Supplement in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Plant-based Immune Health Supplement in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Powder
- Tablets
- Soft Gels
- Liquid
Applications
- Pharmacies and Drug Stores
- Online Retail
- Supermarkets
- Convenience Stores
- Others
Companies covered
- China New Era Group
- INFINITUS
- PERFECT
- By-health
- Suntory
- Bayer AG
- Amway
- USANA Health Sciences
- Swisse
- GNC
- Glanbia
- Blackmores
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Plant-based Immune Health Supplement Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Plant-based Immune Health Supplement Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Plant-based Immune Health Supplement Market Dynamics
- 2.1 Plant-based Immune Health Supplement Industry Trends
- 2.2 Plant-based Immune Health Supplement Industry Drivers
- 2.3 Plant-based Immune Health Supplement Industry Opportunities and Challenges
- 2.4 Plant-based Immune Health Supplement Industry Restraints
3 Plant-based Immune Health Supplement Market by Company
- 3.1 Global Plant-based Immune Health Supplement Company Revenue Ranking in 2025
- 3.2 Global Plant-based Immune Health Supplement Revenue by Company (2021-2026)
- 3.3 Global Plant-based Immune Health Supplement Company Ranking (2024-2026)
- 3.4 Global Plant-based Immune Health Supplement Company Manufacturing Base and Headquarters
- 3.5 Global Plant-based Immune Health Supplement Company Product Type and Application
- 3.6 Global Plant-based Immune Health Supplement Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Plant-based Immune Health Supplement Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Plant-based Immune Health Supplement Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Plant-based Immune Health Supplement Market by Type
- 4.1 Plant-based Immune Health Supplement Type Introduction
- 4.1.1 Powder
- 4.1.2 Tablets
- 4.1.3 Soft Gels
- 4.1.4 Liquid
- 4.2 Global Plant-based Immune Health Supplement Sales Value by Type
- 4.2.1 Global Plant-based Immune Health Supplement Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Plant-based Immune Health Supplement Sales Value by Type (2021-2032)
- 4.2.3 Global Plant-based Immune Health Supplement Sales Value Share by Type (2021-2032)
5 Plant-based Immune Health Supplement Market by Application
- 5.1 Plant-based Immune Health Supplement Application Introduction
- 5.1.1 Pharmacies and Drug Stores
- 5.1.2 Online Retail
- 5.1.3 Supermarkets
- 5.1.4 Convenience Stores
- 5.1.5 Others
- 5.2 Global Plant-based Immune Health Supplement Sales Value by Application
- 5.2.1 Global Plant-based Immune Health Supplement Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Plant-based Immune Health Supplement Sales Value by Application (2021-2032)
- 5.2.3 Global Plant-based Immune Health Supplement Sales Value Share by Application (2021-2032)
6 Plant-based Immune Health Supplement Regional Value Analysis
- 6.1 Global Plant-based Immune Health Supplement Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Plant-based Immune Health Supplement Sales Value by Region (2021-2032)
- 6.2.1 Global Plant-based Immune Health Supplement Sales Value by Region: 2021-2026
- 6.2.2 Global Plant-based Immune Health Supplement Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Plant-based Immune Health Supplement Sales Value (2021-2032)
- 6.3.2 North America Plant-based Immune Health Supplement Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Plant-based Immune Health Supplement Sales Value (2021-2032)
- 6.4.2 Europe Plant-based Immune Health Supplement Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Plant-based Immune Health Supplement Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Plant-based Immune Health Supplement Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Plant-based Immune Health Supplement Sales Value (2021-2032)
- 6.6.2 South America Plant-based Immune Health Supplement Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Plant-based Immune Health Supplement Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Plant-based Immune Health Supplement Sales Value Share by Country, 2025 VS 2032
7 Plant-based Immune Health Supplement Country-level Value Analysis
- 7.1 Global Plant-based Immune Health Supplement Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Plant-based Immune Health Supplement Sales Value by Country (2021-2032)
- 7.2.1 Global Plant-based Immune Health Supplement Sales Value by Country (2021-2026)
- 7.2.2 Global Plant-based Immune Health Supplement Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Plant-based Immune Health Supplement Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Plant-based Immune Health Supplement Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Plant-based Immune Health Supplement Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Plant-based Immune Health Supplement Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Plant-based Immune Health Supplement Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Plant-based Immune Health Supplement Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Plant-based Immune Health Supplement Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Plant-based Immune Health Supplement Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Plant-based Immune Health Supplement Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Plant-based Immune Health Supplement Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Plant-based Immune Health Supplement Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Plant-based Immune Health Supplement Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Plant-based Immune Health Supplement Sales Value Growth Rate (2021-2032)
- 7.7.2 France Plant-based Immune Health Supplement Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Plant-based Immune Health Supplement Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Plant-based Immune Health Supplement Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Plant-based Immune Health Supplement Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Plant-based Immune Health Supplement Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Plant-based Immune Health Supplement Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Plant-based Immune Health Supplement Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Plant-based Immune Health Supplement Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Plant-based Immune Health Supplement Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Plant-based Immune Health Supplement Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Plant-based Immune Health Supplement Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Plant-based Immune Health Supplement Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Plant-based Immune Health Supplement Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Plant-based Immune Health Supplement Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Plant-based Immune Health Supplement Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Plant-based Immune Health Supplement Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Plant-based Immune Health Supplement Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Plant-based Immune Health Supplement Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Plant-based Immune Health Supplement Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Plant-based Immune Health Supplement Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Plant-based Immune Health Supplement Sales Value Growth Rate (2021-2032)
- 7.14.2 China Plant-based Immune Health Supplement Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Plant-based Immune Health Supplement Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Plant-based Immune Health Supplement Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Plant-based Immune Health Supplement Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Plant-based Immune Health Supplement Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Plant-based Immune Health Supplement Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Plant-based Immune Health Supplement Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Plant-based Immune Health Supplement Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Plant-based Immune Health Supplement Sales Value Growth Rate (2021-2032)
- 7.17.2 India Plant-based Immune Health Supplement Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Plant-based Immune Health Supplement Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Plant-based Immune Health Supplement Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Plant-based Immune Health Supplement Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Plant-based Immune Health Supplement Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Plant-based Immune Health Supplement Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Plant-based Immune Health Supplement Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Plant-based Immune Health Supplement Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Plant-based Immune Health Supplement Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Plant-based Immune Health Supplement Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Plant-based Immune Health Supplement Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Plant-based Immune Health Supplement Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Plant-based Immune Health Supplement Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Plant-based Immune Health Supplement Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Plant-based Immune Health Supplement Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Plant-based Immune Health Supplement Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Plant-based Immune Health Supplement Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Plant-based Immune Health Supplement Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Plant-based Immune Health Supplement Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Plant-based Immune Health Supplement Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Plant-based Immune Health Supplement Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Plant-based Immune Health Supplement Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Plant-based Immune Health Supplement Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Plant-based Immune Health Supplement Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Plant-based Immune Health Supplement Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Plant-based Immune Health Supplement Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Plant-based Immune Health Supplement Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Plant-based Immune Health Supplement Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Plant-based Immune Health Supplement Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Plant-based Immune Health Supplement Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Plant-based Immune Health Supplement Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Plant-based Immune Health Supplement Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Plant-based Immune Health Supplement Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Plant-based Immune Health Supplement Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Plant-based Immune Health Supplement Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Plant-based Immune Health Supplement Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Plant-based Immune Health Supplement Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Plant-based Immune Health Supplement Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Plant-based Immune Health Supplement Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Plant-based Immune Health Supplement Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Plant-based Immune Health Supplement Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 China New Era Group
- 8.1.1 China New Era Group Company Information
- 8.1.2 China New Era Group Business Overview
- 8.1.3 China New Era Group Plant-based Immune Health Supplement Revenue and Gross Margin (2021-2026)
- 8.1.4 China New Era Group Plant-based Immune Health Supplement Product Portfolio
- 8.1.5 China New Era Group Recent Developments
- 8.2 INFINITUS
- 8.2.1 INFINITUS Company Information
- 8.2.2 INFINITUS Business Overview
- 8.2.3 INFINITUS Plant-based Immune Health Supplement Revenue and Gross Margin (2021-2026)
- 8.2.4 INFINITUS Plant-based Immune Health Supplement Product Portfolio
- 8.2.5 INFINITUS Recent Developments
- 8.3 PERFECT
- 8.3.1 PERFECT Company Information
- 8.3.2 PERFECT Business Overview
- 8.3.3 PERFECT Plant-based Immune Health Supplement Revenue and Gross Margin (2021-2026)
- 8.3.4 PERFECT Plant-based Immune Health Supplement Product Portfolio
- 8.3.5 PERFECT Recent Developments
- 8.4 By-health
- 8.4.1 By-health Company Information
- 8.4.2 By-health Business Overview
- 8.4.3 By-health Plant-based Immune Health Supplement Revenue and Gross Margin (2021-2026)
- 8.4.4 By-health Plant-based Immune Health Supplement Product Portfolio
- 8.4.5 By-health Recent Developments
- 8.5 Suntory
- 8.5.1 Suntory Company Information
- 8.5.2 Suntory Business Overview
- 8.5.3 Suntory Plant-based Immune Health Supplement Revenue and Gross Margin (2021-2026)
- 8.5.4 Suntory Plant-based Immune Health Supplement Product Portfolio
- 8.5.5 Suntory Recent Developments
- 8.6 Bayer AG
- 8.6.1 Bayer AG Company Information
- 8.6.2 Bayer AG Business Overview
- 8.6.3 Bayer AG Plant-based Immune Health Supplement Revenue and Gross Margin (2021-2026)
- 8.6.4 Bayer AG Plant-based Immune Health Supplement Product Portfolio
- 8.6.5 Bayer AG Recent Developments
- 8.7 Amway
- 8.7.1 Amway Company Information
- 8.7.2 Amway Business Overview
- 8.7.3 Amway Plant-based Immune Health Supplement Revenue and Gross Margin (2021-2026)
- 8.7.4 Amway Plant-based Immune Health Supplement Product Portfolio
- 8.7.5 Amway Recent Developments
- 8.8 USANA Health Sciences
- 8.8.1 USANA Health Sciences Company Information
- 8.8.2 USANA Health Sciences Business Overview
- 8.8.3 USANA Health Sciences Plant-based Immune Health Supplement Revenue and Gross Margin (2021-2026)
- 8.8.4 USANA Health Sciences Plant-based Immune Health Supplement Product Portfolio
- 8.8.5 USANA Health Sciences Recent Developments
- 8.9 Swisse
- 8.9.1 Swisse Company Information
- 8.9.2 Swisse Business Overview
- 8.9.3 Swisse Plant-based Immune Health Supplement Revenue and Gross Margin (2021-2026)
- 8.9.4 Swisse Plant-based Immune Health Supplement Product Portfolio
- 8.9.5 Swisse Recent Developments
- 8.10 GNC
- 8.10.1 GNC Company Information
- 8.10.2 GNC Business Overview
- 8.10.3 GNC Plant-based Immune Health Supplement Revenue and Gross Margin (2021-2026)
- 8.10.4 GNC Plant-based Immune Health Supplement Product Portfolio
- 8.10.5 GNC Recent Developments
- 8.11 Glanbia
- 8.11.1 Glanbia Company Information
- 8.11.2 Glanbia Business Overview
- 8.11.3 Glanbia Plant-based Immune Health Supplement Revenue and Gross Margin (2021-2026)
- 8.11.4 Glanbia Plant-based Immune Health Supplement Product Portfolio
- 8.11.5 Glanbia Recent Developments
- 8.12 Blackmores
- 8.12.1 Blackmores Company Information
- 8.12.2 Blackmores Business Overview
- 8.12.3 Blackmores Plant-based Immune Health Supplement Revenue and Gross Margin (2021-2026)
- 8.12.4 Blackmores Plant-based Immune Health Supplement Product Portfolio
- 8.12.5 Blackmores Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst